Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

References

• MitchellJAAkarasereenontPThiemermannCFlowerRJVaneJRSelectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenaseProc Natl Acad Sci U S A1993902411693116978265610
   PubMed Web of Science ®Google Scholar
• ChamBERoss-LeeLBochnerFImhoffDMMeasurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assayTher Drug Monit1980243653727222191
   PubMed Web of Science ®Google Scholar
• SmithWLMolecular mechanisms of aspirin actionDrug News Perspect19914362366
   Google Scholar
• ProsdocimiMFinessoMGorioACoronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dogAm J Physiol19852484 Pt 2H493H4993838623
   PubMed Web of Science ®Google Scholar
• CerlettiCGambinoMCGarattiniSde GaetanoGBiochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vesselsJ Clin Invest19867813233263088044
   PubMed Web of Science ®Google Scholar
• FitzGeraldGALupinettiMCharmanSACharmanWNPresystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2J Pharmacol Exp Ther19912593104310491762060
   PubMed Web of Science ®Google Scholar
• MuirNNicholsJDCliffordJMStillingsMRHoareRCThe influence of dosage form on aspirin kinetics: implications for acute cardiovascular useCurr Med Res Opin199713105475539327189
   PubMed Web of Science ®Google Scholar
• RowlandMRielgelmaSPharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in manJ Pharm Sci196857813131319
   Web of Science ®Google Scholar
• BroomeTABrownMPGronwallRRCaseyMFMerittKAPharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horsesCan J Vet Res200367429730214620867
   PubMed Web of Science ®Google Scholar
• FitzGeraldGAPedersenAKPatronoCAnalysis of prostacyclin and thromboxane biosynthesis in cardiovascular diseaseCirculation1983676117411776342834
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineCirculation2007116e148e30417679616
   PubMed Web of Science ®Google Scholar
• GerrardJMMeasurements of 6-keto-prostaglandin F1 alpha and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders?Can J Physiol Pharmacol19896789229282688855
   PubMed Web of Science ®Google Scholar
• ZimmermannNWenkAKimUFunctional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgeryCirculation2003108554254712874188
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyICH Topic E9. Statistical principles for clinical trials Available from: http://www.ema.europa.eu/pdfs/human/ich/036396en.pdfAccessed June 6, 2011
   Google Scholar
• VaneJRBakhleYSBottingRMCyclooxygenases 1 and 2Annu Rev Pharmacol Toxicol199838971209597150
   PubMed Web of Science ®Google Scholar
• ChengYAustinSCRoccaBRole of prostacyclin in the cardiovascular response to thromboxane A2Science2002296556753954111964481
   PubMed Web of Science ®Google Scholar
• CerlettiCGambinoMCBucchiFRajtarGRivaEde GoetanoGComparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in manAgents Actions Suppl1986202392483101444
   PubMedGoogle Scholar
• HammCWBassandJ-PAgewallSESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEur Heart J201132232999305421873419
   PubMed Web of Science ®Google Scholar
• ItoSOkaRTsuchidaAYoshiokaHDisposition of single-dose intravenous and oral aspirin in childrenDev Pharmacol Ther1991173–41801861841835
   PubMedGoogle Scholar
• PatronoCGarcía RodríguezLALandolfiRBaigentCLow-dose aspirin for the prevention of atherothrombosisN Engl J Med2005353222373238316319386
   PubMed Web of Science ®Google Scholar
• PatrignaniPFilabozziPPatronoCSelective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjectsJ Clin Invest1982696136613727045161
   PubMed Web of Science ®Google Scholar
• FitzGeraldGAOatesJAHawigerJEndogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in manJ Clin Invest19837136766886338043
   PubMed Web of Science ®Google Scholar
• DillingerJGDrissaASiderisGBiological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery diseaseAm Heart J2012164460060623067920
   PubMed Web of Science ®Google Scholar
• RoccaBSantilliFPitoccoDThe recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetesJ Thromb Haemost20121071220123022471290
   PubMed Web of Science ®Google Scholar
• PascaleSPetrucciGDraganiAAspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewel of the drug targetBlood2012119153595360322234683
   PubMed Web of Science ®Google Scholar
• VejarMHackettDBrunelliCComparison of low-dose aspirin and coronary vasodilators in acute unstable anginaCirculation199081Suppl II4I112403867
   PubMedGoogle Scholar